Date: September 22–23, 2026 | Venue: Singapore
Full Name: Biopharmaceutical Bioprocess Development Summit
Organizer: Enmore Bio | Co-organizer: XDC
Milestone Pharma is delighted to announce our attendance at the 2026 BPD Singapore Summit, a leading regional summit focusing on biopharmaceutical bioprocess innovation across Southeast Asia.
This two-day event gathers global biotech R&D leaders, bioprocess specialists and pharmaceutical practitioners to exchange insights on biomanufacturing workflows, bioconjugate development, GLP-1 formulation, impurity control, regulatory compliance and more.
As a global CRO delivering integrated CMC and drug quality research solutions, Milestone Pharma’s international technical and business team will be stationed at our booth to showcase our full-spectrum compliant technical services:
• Comprehensive CMC & pharmaceutical formulation development for small molecules, peptides, antibodies and bioconjugates
• Full-scope analytical testing: nitrosamine/genotoxic impurity profiling, biologic characterization, stability study & method validation
• Advanced delivery system research including inhaled, nasal and sustained-release formulations
• Packaging compatibility, container closure integrity and filtration validation services
• Global regulatory consulting & registration support aligned with ICH, FDA, EMA and ASEAN standards
We sincerely welcome all industry partners, researchers and investors to visit our booth for face-to-face technical consultations. Let’s discuss customized quality research solutions and explore cross-border biopharma R&D cooperation opportunities across the APAC region.
